EP 3678637 A1 20200715 - MEDROXYPROGESTERONE ACETATE INJECTABLE COMPOSITIONS AND METHODS OF USE
Title (en)
MEDROXYPROGESTERONE ACETATE INJECTABLE COMPOSITIONS AND METHODS OF USE
Title (de)
INJIZIERBARE MEDROXYPROGESTERONACETATZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERWENDUNG
Title (fr)
COMPOSITIONS INJECTABLES D'ACÉTATE DE MÉDROXYPROGESTÉRONE ET LEURS PROCÉDÉS D'UTILISATION
Publication
Application
Priority
IB 2017055404 W 20170907
Abstract (en)
[origin: WO2019048906A1] The disclosure is directed to medroxyprogesterone compositions suitable for subcutaneous injection comprising about 360 mg/ml to 440 mg/ml or about 160 mg/ml to 240 mg/ml medroxyprogesterone acetate, 1.7 mg/ml to 2.3 mg/ml docusate sodium, polyethylene glycol, and water. Methods of using these compositions are also described.
IPC 8 full level
A61K 9/00 (2006.01); A61K 9/10 (2006.01); A61K 31/57 (2006.01); A61K 47/10 (2017.01); A61K 47/18 (2017.01); A61K 47/20 (2006.01)
CPC (source: EP)
A61K 9/0019 (2013.01); A61K 9/10 (2013.01); A61K 31/57 (2013.01); A61K 47/10 (2013.01); A61K 47/183 (2013.01); A61K 47/20 (2013.01)
Citation (search report)
See references of WO 2019048906A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
DOCDB simple family (application)
IB 2017055404 W 20170907; EP 17778342 A 20170907